Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The present study hypothesizes that the systematic use of bilateral internal mammary artery (BIMA) grafting is feasible in the practice of a University Cardiac Surgery Institution for the treatment of multivessel coronary artery disease (primary hypothesis). The secondary study hypothesis is that the BIMA grafting meets the safety endpoint compared with the conventional surgical strategy entailing left mammary artery grafting plus great saphenous vein grafts to revascularize the remaining coronary targets. The tertiary study hypothesis is that the BIMA grafting yields better follow-up results in terms of recurrence of symptoms related to coronary disease, of repeat revascularization and of cardiac mortality compared with patients treated with the conventional surgical strategy entailing left mammary artery grafting plus great saphenous vein grafts to revascularize the remaining coronary targets.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| BIMA Grafting Group | Group consists of patients who received bilateral internal mammary artery grafting for treatment of severe coronary disease since June 2012. |
| |
| Control Group | This Group consists of historical control patients who received conventional coronary artery bypass grafting (left mammary artery graft only plus great saphenous vein grafts) in the 2010-2012 period, and who are propensity-matched to the BIMA Group patients. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| BIMA Grafting | Procedure | Both the left and the right internal mammary arteries are harvested and used to revascularize the two major coronary targets. Further coronary targets may be revascularized using either great saphenous vein or radial artery grafts, if present. |
| Measure | Description | Time Frame |
|---|---|---|
| Feasibility of systematic BIMA grafting | Starting in June 2012, all clinical data concerning patients undergoing BIMA grafting are recorded, including the baseline demographics and risk factors, the operative time, all in-hospital complications, duration of Intensive care Unit and Hospital stays, the amount of transfusion of blood products. | 2012-2014 (2 years) |
| Measure | Description | Time Frame |
|---|---|---|
| Clinical results at follow-up | The patients enrolled in the study are subjected to longitudinal follow-up to determine the rate of residual myocardial ischemia (periodical stress ECG), of recurrent symptoms of coronary disease, and of any adverse cardiac event (periodical follow-up visits). | 2012-2016 (4 years) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
The target study population consists of 1,000 patients undergoing isolated coronary surgery for multivessel disease within a Cardiac Surgery University Department.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Massimo Massetti, MD, PhD | Contact | 0039-0630154639 | m.massetti@rm.unicatt.it |
| Name | Affiliation | Role |
|---|---|---|
| Massimo Massetti, MD | Division of Cardiac Surgery, Catholic University | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Policlinico Universitario "A. Gemelli" | Recruiting | Rome | Italy | 00168 | Italy |
Not provided
Not provided
Not provided
Not provided
| Left-only mammary artery grafting | Procedure | These patients had only the left mammary artery harvested and used to revascularize the major coronary target. Great saphenous vein grafts and/or radial artery grafts were employed to revascularize the remaining targets. |
|